Lannett Company, Inc. (LCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
29 Pages - GLDATA50974
$250.00

Summary

Lannett Company, Inc. (Lannett) carries out development, manufacturing, marketing and distribution of generic versions of branded pharmaceutical products. The company offers generic pharmaceuticals for medical indications such as migraine headache, cardiovascular, pain management, glaucoma, prescription vitamin, thyroid deficiency, gallstone prevention, antibiotics, obesity and other generic pharmaceutical products. Lannett also offers laboratory services, product formulation and development services, and other services such as granulation, blending, encapsulation, compression, coating and packaging solid dosage forms. The company sells its pharmaceutical products across the US to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private-label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations and health maintenance organizations. Lannett is headquartered in Pennsylvania, the US.

Lannett Company, Inc. (LCI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Lannett Company, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Lannett to Acquire Estradiol Tablets and Selegiline Hydrochloride Capsules 11
Private Equity 12
Advent International and Avista Capital Partners to Terminate Acquisition of Kremers Urban Pharma for USD1.525 Billion 12
Partnerships 14
Lannett Enters into Co-Marketing Agreement with Sunshine Lake 14
Lannett Company Extends Distribution Agreement With Jerome Stevens Pharma 15
Panacea Biotec Enters Into R&D Agreement With Kremers Urban For Generic Drugs 16
Equity Offering 17
Lannett Completes Public Offering Of Shares For US$76.5 Million 17
Lannett Files Shelf Registration Statement For Public Offering Of Securities For Up To US$64 Million 19
Lannett Completes Exercise Of Underwriter's Allotment Option For US$16 Million 20
Acquisition 22
Lannett Acquires Kremers Urban Pharma for USD1.23 Billion 22
Lannett Acquires Silarx Pharma for USD42 Million 24
Lupin and Cipla May Acquire Kremers Urban Pharma 25
Lannett Company, Inc. - Key Competitors 26
Key Employees 27
Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
Lannett Company, Inc., Pharmaceuticals & Healthcare, Key Facts, 2015 1
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Lannett Company, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Lannett Company, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Lannett to Acquire Estradiol Tablets and Selegiline Hydrochloride Capsules 11
Advent International and Avista Capital Partners to Terminate Acquisition of Kremers Urban Pharma for USD1.525 Billion 12
Lannett Enters into Co-Marketing Agreement with Sunshine Lake 14
Lannett Company Extends Distribution Agreement With Jerome Stevens Pharma 15
Panacea Biotec Enters Into R&D Agreement With Kremers Urban For Generic Drugs 16
Lannett Completes Public Offering Of Shares For US$76.5 Million 17
Lannett Files Shelf Registration Statement For Public Offering Of Securities For Up To US$64 Million 19
Lannett Completes Exercise Of Underwriter's Allotment Option For US$16 Million 20
Lannett Acquires Kremers Urban Pharma for USD1.23 Billion 22
Lannett Acquires Silarx Pharma for USD42 Million 24
Lupin and Cipla May Acquire Kremers Urban Pharma 25
Lannett Company, Inc., Key Competitors 26
Lannett Company, Inc., Key Employees 27
Lannett Company, Inc., Other Locations 28
Lannett Company, Inc., Subsidiaries 28

List of Figures
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Lannett Company, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838